Clinical Trials Directory

Trials / Completed

CompletedNCT05771857

Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19

Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19: Retrospective Cohort Study of 415 Cases

Status
Completed
Phase
Study type
Observational
Enrollment
415 (actual)
Sponsor
Mohammed VI University Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Our study has the objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19.

Detailed description

Introduction: COVID 19 pandemic continues to progress with a considerable mortality and morbidity throughout the world since its emergence in December 2019. Many studies were conducted to identify the predictive factors of mortality of those infected with the virus. The previous studies noticed that obesity seems to be associated with severe form of respiratory distress syndrome. Our study has the objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19. Methods: investigators led a retrospective monocentric, descriptive and analytic study, in the department of anesthesia and intensive care unit of the university hospital of Mohamed VI Oujda, in Morocco, from March 2020 to October 2021, including all the patients tested positive for the infection.

Conditions

Interventions

TypeNameDescription
DEVICEObesitythe objective of identifying the epidemiological profil of the patients, as well as, the clinical, radiological and prognosis of obese patients with covid 19

Timeline

Start date
2020-03-01
Primary completion
2021-09-30
Completion
2021-10-01
First posted
2023-03-16
Last updated
2023-03-16

Locations

1 site across 1 country: Morocco

Source: ClinicalTrials.gov record NCT05771857. Inclusion in this directory is not an endorsement.